[PDF][PDF] Pembrolizumab for advanced basal cell carcinoma: an investigator-initiated, proof-of-concept study
ALS Chang, DC Tran, JGD Cannon, S Li… - Journal of the American …, 2019 - Elsevier
ALS Chang, DC Tran, JGD Cannon, S Li, M Jeng, R Patel, L Van der Bokke, A Pague…
Journal of the American Academy of Dermatology, 2019•ElsevierFunding Source: Merck, Sharp, and Dohme, Inc. provided funding for this study but 63 were
not involved in writing of the manuscript, decision to submit for publication, data 64
collection, analysis, interpretation, trial design, patient recruitment or any other aspect 65
pertinent to the study. The authors have not been paid to write this article by a 66
pharmaceutical company or other agency. The corresponding author had full access to 67
all the data in the study and final responsibility for the decision to submit for publication. 68 …
not involved in writing of the manuscript, decision to submit for publication, data 64
collection, analysis, interpretation, trial design, patient recruitment or any other aspect 65
pertinent to the study. The authors have not been paid to write this article by a 66
pharmaceutical company or other agency. The corresponding author had full access to 67
all the data in the study and final responsibility for the decision to submit for publication. 68 …
Funding Source: Merck, Sharp, and Dohme, Inc. provided funding for this study but 63 were not involved in writing of the manuscript, decision to submit for publication, data 64 collection, analysis, interpretation, trial design, patient recruitment or any other aspect 65 pertinent to the study. The authors have not been paid to write this article by a 66 pharmaceutical company or other agency. The corresponding author had full access to 67 all the data in the study and final responsibility for the decision to submit for publication. 68 69
Elsevier